GlassScriptPhysician profile
Tarun Mehra
NPI 1659374700
$11,943.41
in general payments reported to CMS, 2019-2025
45 companies · $1,656 in 2025
The $1,656 reported for 2025 was more than what 91% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,287 · 2020: $1,425 · 2021: $1,767 · 2022: $1,801 · 2023: $1,785 · 2024: $2,222 · 2025: $1,656.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,663.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,663.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $2,873.62 | 2019-2025 | Farxiga, Airsupra, Breztri |
| Novo Nordisk INC | $1,182.18 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Abbvie INC. | $1,076.33 | 2021-2025 | |
| Abbott Laboratories | $844.04 | 2021-2025 | Freestyle Libre 3, Freestyle Libre 2 |
| Lilly USA, LLC | $639.95 | 2019-2025 | Mounjaro, Zepbound, Emgality |
| Glaxosmithkline, LLC. | $484.27 | 2019-2025 | Trelegy Ellipta |
| Exact Sciences Corporation | $465.33 | 2023-2025 | Cologuard Collection Kit |
| Boehringer Ingelheim Pharmaceuticals, INC. | $438.51 | 2019-2025 | Jardiance |
| Pfizer INC. | $390.11 | 2020-2025 | |
| Phathom Pharmaceuticals, INC. | $344.56 | 2023-2025 | Voquezna |
| Novartis Pharmaceuticals Corporation | $337.51 | 2019-2024 | |
| Amgen INC. | $255.99 | 2019-2025 | Uplizna |
| Janssen Pharmaceuticals, INC | $231.61 | 2019-2024 | Xarelto |
| Esperion Therapeutics, INC. | $205.41 | 2020-2021 | |
| Merck Sharp & Dohme LLC | $196.50 | 2019-2025 | Gardasil 9, Capvaxive, Gardasil |
Show all 45 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tarun Mehra listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.